Clinical Trial Update: A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS) [Phase 4]

View source ↗

Summary

Phase IV clinical trial update for dimethyl fumarate enteric-coated capsules in relapsing multiple sclerosis. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Dimethyl Fumarate Enteric-coated Capsules (dimethyl fumarate)

Snippet

Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd. | Conditions: Relapsing Multiple Sclerosis | Phase 4 | Status: NOT_YET_RECRUITING